Buying and selling of own real estate
BARRACUDA INVEST AS
Revenue 2024
NOK 1.6m
Operating profit
NOK 443,000
Equity
NOK 7.1m
Incorporated
1998
Share capital
NOK 159,000
Roles
Revisor
Styrets lederMårten Wigstøl
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| MÅRTEN WIGSTØL | 100.0% | 159290.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| COMBRA INVEST AS | Active | 33.3% | 10000.000000 |
| BRACOM AS | Active | 18.8% | 11725.000000 |
| LYBE SCIENTIFIC AS | Active | 4.2% | 7373.000000 |
| KEIMON MEDICAL AS | Active | 2.2% | 225.000000 |
| CIMON MEDICAL AS | Active | 1.5% | 17528.000000 |
| CIMON MEDICAL AS | Active | 0.7% | 8718.000000 |
| DEFIBRIO AS | Active | 0.6% | 1000.000000 |
| REMOVAID AS | Active | 0.0% | 2000.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.